PRACTECAL-PKPD Sub Study
Conditions: Multi-drug Resistant Tuberculosis; Extensively Drug-Resistant Tuberculosis; Pulmonary Tuberculosis Interventions: Drug: Bedaquiline; Drug: Pretomanid; Drug: Moxifloxacin; Drug: Linezolid; Drug: Clofazimine Sponsors: Medecins Sans Frontieres, Netherlands; London School of Hygiene and Tropical Medicine; Global Alliance for TB Drug Development; University College, London; Drugs for Neglected Diseases; Swiss Tropical & Public Health Institute; eResearch Technology, Inc.; Ministry of Health, Republic of Uzbekistan; World Hea...
Source: ClinicalTrials.gov - September 9, 2019 Category: Research Source Type: clinical trials
PRACTECAL-PKPD: Sub-study for TB-PRACTECAL Clinical Trial
Conditions: Multi-drug Resistant Tuberculosis; Extensively Drug-Resistant Tuberculosis; Pulmonary Tuberculosis Interventions: Drug: Bedaquiline; Drug: Pretomanid; Drug: Moxifloxacin; Drug: Linezolid; Drug: Clofazimine Sponsors: Medecins Sans Frontieres, Netherlands; London School of Hygiene and Tropical Medicine; Global Alliance for TB Drug Development; University College, London; Drugs for Neglected Diseases; Swiss Tropical & Public Health Institute; eResearch Technology, Inc.; Ministry of Health, Republic of Uzbekistan; World Hea...
Source: ClinicalTrials.gov - September 9, 2019 Category: Research Source Type: clinical trials
PRACTECAL-PKPD Sub Study
Conditions: Multi-drug Resistant Tuberculosis; Extensively Drug-Resistant Tuberculosis; Pulmonary Tuberculosis Interventions: Drug: Bedaquiline; Drug: Pretomanid; Drug: Moxifloxacin; Drug: Linezolid; Drug: Clofazimine Sponsors: Medecins Sans Frontieres, Netherlands; London School of Hygiene and Tropical Medicine; Global Alliance for TB Drug Development; University College, London; Drugs for Neglected Diseases; Swiss Tropical & Public Health Institute; eResearch Technology, Inc.; Ministry of Health, Republic of Uzbekistan; World Hea...
Source: ClinicalTrials.gov - September 9, 2019 Category: Research Source Type: clinical trials